Back to search
Anti-Glomerular Basement Membrane Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-Glomerular Basement Membrane Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Anti-Glomerular Basement Membrane Disease trials you may qualify forAn Exploratory, Single-Arm, Open-Label, Dose-Escalation Study of the Safety, Tolerability, PK, PD, and Efficacy of Anti-CD19/BCMA Universal CAR-T Therapy RD06-0…
This study aims to clarify the prognosis of the rare but severe condition anti-glomerular basement membrane disease (anti-GBM disease also known as Goodpastures…
An open-label, controlled, randomised, multi-centre Phase 3 trial evaluating renal function in patients with severe anti-GBM disease comparing imlifidase and st…
Anti-neutrophil cytoplasmic antibodies (ANCA), directed against myeloperoxidase (MPO) and against proteinase 3 (PR3), have a pathogenic role during ANCA (AAV) v…
Introduction and background : Glomerulonephritis and auto-immune diseases are often associated. Lupus nephritis (LN) is one of the major clinical manifestation…